Bio-identical Hormone & Peptide Specialists

CJC-1295 + Ipamorelin | Two Signals, One Synergistic Effect

You train consistently, take recovery seriously, and you’re in this for the long haul. This stack is built for exactly that – giving your body the hormonal environment it needs to keep up with everything you’re asking of it.

Peak Performance pathway › CJC-1295 + Ipamorelin See every Peak Performance option
shutterstock

Why Two Peptides Work Better Than One

CJC-1295 and Ipamorelin are both growth hormone-stimulating peptides. But they act on different receptors: CJC-1295 is a long-acting GHRH analog, while Ipamorelin acts on the growth hormone-releasing peptide (ghrelin) receptor. This exact pair has not yet been tested in clinical trials, but in human studies combining these two classes of signal released growth hormone synergistically.12

Think of it this way: Ipamorelin triggers a short pulse of growth hormone. CJC-1295 lasts for days and raises background growth hormone levels while your natural pulses continue. Because your pituitary still does the releasing, output stays under your body’s own controls rather than being overridden.34

Within the Peak Performance Suite, this is the stack we reach for when patients are ready to go further – whether that means stepping into it as a primary protocol or building on an existing growth hormone optimization plan.

What Our Patients Notice

What patients typically report

Most patients begin noticing changes within 4-8 weeks. Here’s what patients commonly report.

shutterstock

Does This Sound Like You?

CJC-1295 + Ipamorelin tends to be a strong fit for men and women over 35 who are performance-focused, active, and frustrated that their body isn’t keeping pace with their effort and commitment.

You might be a good candidate if you:

  • Train consistently but feel like your recovery has slowed significantly
  • Are putting in the work but not seeing the body composition results you used to
  • Wake up feeling like you never fully recovered from the day before
  • Have noticed a drop in energy, drive, or mental sharpness that you can’t explain
  • Want a protocol designed for long-term performance, not a quick fix
  • Are ready to move into a comprehensive growth hormone optimization program

Dr. Varano or his Medical Provider Team will review your labs, symptoms, and goals before any protocol is recommended – nothing is prescribed without a full clinical picture.

Our Foundational Assessment is where it starts. It gives us – and you – everything we need to build the right plan.

shutterstock

The YoungerMeMD CJC-1295 + Ipamorelin Program

Every CJC-1295 + Ipamorelin protocol follows the same three steps, so you know the full cost before you start.

STEP 1

Foundational Assessment

$599one-time

Your starting point is a comprehensive, 1-hour deep dive:

  • Full lab testing & bloodwork
  • Medical + lifestyle evaluation
  • Personalized performance plan
Book Your Assessment
STEP 2

Peptide Membership

$279/month

Your membership includes:

  • Direct access to your clinical team
  • 3–4 visits per year
  • Unlimited messaging support
  • Supplement discounts
  • Ongoing plan optimization
STEP 3

CJC-1295 + Ipamorelin Protocol

$175/month

Amplified results for body composition, recovery, and performance.

  • A small subcutaneous injection, typically in the abdomen, given at home before bed
  • Prescribed only after a full evaluation of your labs and history
  • Adjusted over time as part of your membership

How is it taken?

It’s a subcutaneous injection – small needle, typically in the abdomen – given at home before bed. Our YoungerMeTeam walks you through everything and stays available for questions as you get started.

Sleep and recovery improvements often show up within the first few weeks. Body composition and energy changes build over 4-8 weeks, with the most significant results typically coming at the 3-6 month mark with consistent use.

Both peptides work within your body’s own regulatory systems – there is no external growth hormone introduced – and short-term studies found each generally well tolerated. Human data are limited, however, and long-term safety has not been established.1213 At YoungerMeMD, this protocol is never prescribed without a full evaluation by Dr. Varano.

Absolutely. CJC-1295 + Ipamorelin fits naturally within a broader hormone optimization protocol and can be incorporated alongside BHRT or other peptide programs depending on your goals and where you are in your health journey. Every protocol is built individually – nothing is stacked without clinical justification from your Provider.

CJC-1295 + Ipamorelin is offered through YoungerMeMD’s membership-based model, which operates outside of traditional insurance. Your membership includes physician oversight, ongoing protocol management, and the personalized attention that insurance-based care isn’t designed to provide.

CJC-1295 and Ipamorelin work through different pathways. Ipamorelin triggers a short growth hormone pulse, while long-acting CJC-1295 raises baseline growth hormone with natural pulses preserved. The combination itself has not yet been studied in clinical trials.34

No. Both peptides work within your body’s own regulatory systems and no external growth hormone is introduced123, and the protocol is only prescribed after a full clinical evaluation.

Questions We Hear All the Time

You Put in the Work. Your Body Should Too.

The version of you that recovers fast, builds lean, sleeps deep, and performs at a high level year after year – that’s not behind you. It’s what this protocol is designed to help you get back to.

CJC-1295 + Ipamorelin is one of the most effective tools we have for patients who are serious about performance and longevity. And it starts with understanding your full picture.

Book a Peptide Consult and let’s look at what your labs are telling us. From there, Dr. Varano will build a protocol that fits your goals, your body, and how you want to live.

References

  1. Bowers CY, Reynolds GA, Durham D, et al. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990. PMID 2108187 · doi:10.1210/jcem-70-4-975↩
  2. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998. PMID 9849822 · doi:10.1530/eje.0.1390552↩
  3. Gobburu JV, Agersø H, Jusko WJ, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res 1999. PMID 10496658 · doi:10.1023/a:1018955126402↩
  4. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab 2006. PMID 17018654 · doi:10.1210/jc.2006-1702↩
  5. Makimura H, Feldpausch MN, Rope AM, et al. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial. J Clin Endocrinol Metab 2012. PMID 23015655 · PMC3513535 · doi:10.1210/jc.2012-2794↩
  6. Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007. PMID 17227934 · doi:10.7326/0003-4819-146-2-200701160-00005↩
  7. Liu H, Bravata DM, Olkin I, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med 2008. PMID 18347346 · doi:10.7326/0003-4819-148-10-200805200-00215↩
  8. Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med 2008. PMID 18981485 · PMC2757071 · doi:10.7326/0003-4819-149-9-200811040-00003↩
  9. Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 1996. PMID 9085516 · doi:10.1093/sleep/19.suppl_10.s221↩
  10. Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000. PMID 10938176 · doi:10.1001/jama.284.7.861↩
  11. Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011. PMID 21602453 · doi:10.1210/jc.2011-0179↩
  12. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab 2006. PMID 16352683 · doi:10.1210/jc.2005-1536↩
  13. Beck DE, Sweeney WB, McCarter MD. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis 2014. PMID 25331030 · doi:10.1007/s00384-014-2030-8↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify